GSDMD and acute kidney injury: Pyroptosis, a lesser-explored pathway in cisplatin-induced AKI, involves NF-κB-mediated activation of the NLRP3/Caspase-1/Gasdermin D (GSDMD) pathway, as confirmed in the AKI model post-cisplatin treatment [149].